Brinker Capital Investments, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Brinker Capital Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$83.14 - $145.99 $252,579 - $443,517	3,038 Added 26.57%	14,471 $2.11 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $145,195 - $188,511	-1,319 Reduced 10.34%	11,433 $1.36 Million
Q4 2021 Feb 08, 2022	BUY	$99.73 - $148.48 $875,629 - $1.3 Million	8,780 Added 221.05%	12,752 $1.76 Million
Q2 2021 Aug 03, 2021	BUY	$65.78 - $105.02 $3,815 - $6,091	58 Added 1.48%	3,972 $386,000
Q1 2021 May 12, 2021	SELL	$64.07 - $91.75 $42,798 - $61,289	-668 Reduced 14.58%	3,914 $268,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $298,150 - $450,135	4,582 New	4,582 $393,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.